DOCUSIGN, INC. |
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||||||||
(Unaudited) |
|||||||||||||||
Three Months Ended January 31, |
Year Ended January 31, |
||||||||||||||
(in thousands) |
2020 |
2019 |
2020 |
2019 |
|||||||||||
Cash flows from operating activities: |
|||||||||||||||
Net loss |
$ |
(47,407) |
$ |
(66,244) |
$ |
(208,359) |
$ |
(426,458) |
|||||||
Adjustments to reconcile net loss to net cash used in operating activities |
|||||||||||||||
Depreciation and amortization |
13,266 |
12,003 |
50,182 |
38,027 |
|||||||||||
Amortization of deferred contract acquisition and fulfillment costs |
20,387 |
12,223 |
69,747 |
42,112 |
|||||||||||
Amortization of debt discount and transaction costs |
6,742 |
6,360 |
26,389 |
9,507 |
|||||||||||
Non-cash operating lease costs |
5,592 |
— |
19,435 |
— |
|||||||||||
Stock-based compensation expense |
55,605 |
49,271 |
206,404 |
410,978 |
|||||||||||
Deferred income taxes |
1,245 |
2,346 |
1,287 |
(5,001) |
|||||||||||
Other |
401 |
2,879 |
(1,741) |
800 |
|||||||||||
Changes in operating assets and liabilities |
|||||||||||||||
Accounts receivable |
(78,377) |
(43,937) |
(63,293) |
(42,571) |
|||||||||||
Contract assets |
5,715 |
1,430 |
(1,508) |
4,204 |
|||||||||||
Prepaid expenses and other current assets |
(1,106) |
(900) |
(3,142) |
(3,283) |
|||||||||||
Deferred contract acquisition and fulfillment costs |
(37,923) |
(28,324) |
(115,723) |
(80,869) |
|||||||||||
Other assets |
612 |
656 |
1,538 |
2,658 |
|||||||||||
Accounts payable |
1,543 |
(1,390) |
3,849 |
(7,380) |
|||||||||||
Accrued expenses and other liabilities |
4,662 |
(1,122) |
9,353 |
6,449 |
|||||||||||
Accrued compensation |
12,329 |
23,868 |
5,636 |
26,039 |
|||||||||||
Contract liabilities |
85,957 |
65,018 |
130,266 |
100,874 |
|||||||||||
Operating lease liabilities |
(3,738) |
— |
(14,624) |
— |
|||||||||||
Net cash provided by operating activities |
45,505 |
34,137 |
115,696 |
76,086 |
|||||||||||
Cash flows from investing activities: |
|||||||||||||||
Purchases of marketable securities |
(107,318) |
(415,132) |
(861,252) |
(415,132) |
|||||||||||
Maturities of marketable securities |
166,599 |
— |
627,309 |
— |
|||||||||||
Purchases of strategic investments |
— |
— |
(15,500) |
— |
|||||||||||
Cash paid for acquisition, net of acquired cash |
— |
— |
— |
(218,779) |
|||||||||||
Purchases of property and equipment |
(29,975) |
(11,317) |
(72,046) |
(30,413) |
|||||||||||
Net cash provided by (used in) investing activities |
29,306 |
(426,449) |
(321,489) |
(664,324) |
|||||||||||
Cash flows from financing activities: |
|||||||||||||||
Proceeds from issuance of convertible senior notes, net of initial purchasers' discounts and transaction costs |
— |
— |
— |
560,756 |
|||||||||||
Purchase of capped calls related to issuance of convertible senior notes |
— |
— |
— |
(67,563) |
|||||||||||
Proceeds from issuance of common stock in initial public offering, net of underwriting commissions |
— |
— |
— |
529,305 |
|||||||||||
Payment of tax withholding obligation on RSU settlement |
(41,216) |
(215,332) |
(166,504) |
(215,332) |
|||||||||||
Proceeds from exercise of stock options |
9,914 |
34,846 |
72,177 |
50,211 |
|||||||||||
Proceeds from employee stock purchase plan |
— |
— |
23,872 |
— |
|||||||||||
Payment of deferred offering costs |
— |
(319) |
— |
(4,011) |
|||||||||||
Other financing |
— |
(250) |
— |
(250) |
|||||||||||
Net cash provided by (used in) financing activities |
(31,302) |
(181,055) |
(70,455) |
853,116 |
|||||||||||
Effect of foreign exchange on cash, cash equivalents and restricted cash |
(137) |
(2,955) |
(447) |
(4,136) |
|||||||||||
Net increase (decrease) in cash, cash equivalents and restricted cash |
43,372 |
(576,322) |
(276,695) |
260,742 |
|||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
198,111 |
1,094,500 |
518,178 |
257,436 |
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
$ |
241,483 |
$ |
518,178 |
$ |
241,483 |
$ |
518,178 |